- Home
- Formulary
Contents (IMF 26, September 2019)
Medicines
- 1.▌ Gastro-Intestinal Drugs
- 2.▌ Cardiovascular Drugs
-
2.1.Hypertension, Heart Failure
- 2.1.1.Angiotensin Converting Enzyme Inhibitors (ACEIs) and Combinations
- 2.1.2.Angiotensin II Antagonists (AIIAs, ARBs) and Combinations
- 2.1.3.Renin Inhibitors and Combinations
- 2.1.4.Alpha-Blockers
- 2.1.5.Centrally Acting Antihypertensives
- 2.1.6.Adrenergic Neurone Blockers
- 2.1.7.Beta-Blockers and Combinations
- 2.2.Calcium Channel Blockers, Nitrates, Other Antianginals
- 2.3.Lipid Regulating Drugs
- 2.4.Sympathomimetics
- 2.5.Antiarrhythmics
-
2.6.Anticoagulants, Antiplatelets, Antithrombotics
- 2.6.1.Heparin, Heparin Flush Solutions, Heparinoids
- 2.6.2.Synthetic Activated Factor X (Xa) Inhibitors
- 2.6.3.Direct Thrombin Inhibitors, Reversal Agents
- 2.6.4.Heparin Antagonists
- 2.6.5.Oral Anticoagulants
- 2.6.6.Antiplatelets Excluding Heparin
- 2.6.7.Non-Steroidal Antiplatelets, Aspirin
- 2.6.8.Other Antiplatelets
- 2.6.9.Antithrombotics, Enzymes and Proteins
- 2.7.Anti-Fibrinolytics and Haemostatics
- 2.8.Positive Inotropes
- 2.9.Diuretics
-
2.1.Hypertension, Heart Failure
- 3.▌ Central Nervous System Drugs
- 4.▌ Analgesics, Anti-Inflammatories, Musculoskeletal Disorders
- 5.▌ Respiratory, Allergic Disorders
- 6.▌ Ear, Nose, Oropharynx
- 7.▌ Ophthalmology
- 8.▌ Obstetrics, Gynaecology, Urological Disorders
- 9.▌ Infectious Diseases
- 10.▌ Dermatology
- 10.1.Acne, Rosacea, Actinic Keratosis
- 10.2.Topical Anti-Infectives
- 10.3.Emollients, Barriers, Topical Antipruritics
- 10.4.Topical Corticosteroids And Combinations
- 10.5.Eczema, Psoriasis, Scalp Disorders
- 10.6.Warts, Corns, Calluses
- 10.7.Scabies, Head Lice
- 10.8.Miscellaneous Dermatologicals
- 10.9.Wound Care
- 11.▌ Endocrinology
- 12.▌ Immunology, Vaccines
- 13.▌ Oncology, Immunosuppression
- 14.▌ Anaesthesia
- 15.▌ Toxicology
- 16.▌ Haematology, Obesity, Metabolic Disorders
Nutritional Supplements
Herbal Preparations
Appendix I: Clinical Utilities
- NEW in IMF
- HPRA Pharmacovigilance Information
- HPRA Adverse Reaction Report Form
- HPRA Quality Defect Report Card (Ireland)
- HSE Medicines Management Programme Preferred Medicines
- HSE Routine Childhood Immunisation Schedule for Ireland
- RCSI Prescription Writing in Ireland, New Controlled Drugs Requirement
- Pharmaceutical Pricing and Reimbursement in Ireland
- Abbreviations Used in IMF
- Noteworthy Excipients in IMF